Parallax Volatility Advisers, L.P. Atara Biotherapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $1,885 - $4,062	99 New	99 $2,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $10,900 - $13,528	-311 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $10,931 - $16,000	311 New	311 $11,000
Q1 2018 May 15, 2018	SELL	$18.0 - $48.35 $71,064 - $190,885	-3,948 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.2 - $18.1 $52,113 - $71,458	3,948	3,948 $71,000

3.07M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $762M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.